Prostate Cancer Prospective Cohort

DNA will be isolated from each person and then studied for the presence of certain genes that
may increase the chance of developing prostate cancer. Certain genes will also be studied in
patients with known prostate cancer to determine if they increase the chance of cancer
spreading to other parts of the body and decrease one's chance of being cured. Small
differences in genes can slightly affect their ability to function. While these differences
are normal, they may influence the way the cancer responds to therapy. An understanding of
which genes increase (or decrease) the chance of being cured of a disease, such as prostate
cancer, will improve our ability to take care of patients more effectively.

A second purpose of this study is to collect blood and cancer tissue for future studies.
While the small differences in genes may be the best marker of bad cancer, it is also
possible that proteins in blood or tumor may be a better marker.

Inclusion Criteria:

- Newly diagnosed patients: 1. newly diagnosis of prostate cancer 2. untreated except
for neoadjuvant systemic therapy.

Exclusion Criteria:

- Newly diagnosed patients: 1. inability to give informed consent